Pharmacology of Selected Opioid Analgesics

Similar documents
Pharmacology of Selected Opioid Analgesics

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Module II Opioids 101 Opiate Opioid

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

OPIOIDS. Testing and Interpretation

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Given a group of definitions, select the definition of analgesia.

Opioids Research to Practice

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

Pain Management Strategies Webinar/Teleconference

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

Opioids Research to Practice

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

Opioids Research to Practice

Dr. Hiwa K. Saaed. PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Analgesic

10 mg hydrocodone equals how much oxycodone

Buprenorphine pharmacology

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM

disease or in clients who consume alcohol on a regular basis. bilirubin

Opioids Research to Practice

Steven Prakken MD Director Medical Pain Service Duke Pain Medicine

Treating Opioid Use Disorders: An Update for Counselors and Other Providers

HIV/AIDS Definition: CDC Classification of HIV Infection Stage 1: Stage 2: Stage 3: Risk Factors

Opioids. Sergio Hernandez, MD

Prescription Opioid Addiction

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

DBL NALOXONE HYDROCHLORIDE INJECTION USP

Opioid Replacement Therapy

Analgesics OPIOID ANALGESICS

SW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Prescription Opioids

Methadone Maintenance

1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I

5/29/2015. Responding to the Opioid Crisis. Responding to the Opioid Crisis. Objectives

Opioids Research to Practice

Opioids. Robin Moorman Li I. OVERVIEW II. OPIOID RECEPTORS

2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Heroin, Fentanyl and Other Opioids. Steve Hanson

People inject, sniff, snort, or smoke heroin. Some people mix heroin with crack cocaine, a practice called speedballing.

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

Nalbuphine morphine cross reactivity

Opioids. October 29, Addiction Medicine Review Course CSAM, Newport Beach, CA

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

WORRIED ABOUT PAIN AFTER ORAL SURGERY?

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

VES. Ves. Oxycodone vicodin is or hydrocodone Oxycodone is considered heroin. Cancer oxycodone for acetaminophen pain. Pill u23 green oxycodone pill

Pharmacology of Opioid Analgesics

Pain is a more terrible Lord of mankind than even death itself.

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

OPIOID REPLACEMANT THERAPY: AN OVERVIEW

Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans

Dr Alistair Dunn. General Practitioner Whangarei

Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine

Opioid dependence and buprenorphine treatment

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

GOALS AND OBJECTIVES

CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Optimizing Suboxone in Opioid Addicts

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue

Session 7: Opioids and Club Drugs 7-1

Brief Pain Surveys. Developed by: Betty R. Ferrell, PhD, FAAN and Margo McCaffery RN, MSN, FAAN

UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14. Cynthia Kim and Stephen Wilson

Medication Assisted Treatment. Michael Palladini, RPh MBA CAC

Talking with your doctor

Drug Screening: Things You Need to Know

Understanding and Combating the Heroin Epidemic

Opioid Use Disorders as a Brain Disease Why MAT is so important. Ron Jackson, M.S.W., L.I.C.S.W.

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

Analgesia is a labeled indication for all of the approved drugs I will be discussing.

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Module Two: Pharmacotherapies for Opioid Substitution Treatment

PAIN MANAGEMENT COMPETENCY

PARACOD Tablets (Paracetamol + Codeine phosphate)

Chapter31. Opioid Analgesics & Antagonists

T employed method for the management of pain due

Session II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids

3/15/2018. Pain. Pain. Opioid Analgesics Addiction. Pain

National Council on Patient Information and Education

Buprenorphine as a Treatment Option for Opioid Use Disorder

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Review of Pain Management with Clinical and Regulatory Updates

Transcription:

Pharmacology of Selected Opioid Analgesics Harvey Berman, PhD, MPH Department of Pharmacology and Toxicology hberman@buffalo.edu 829-2658

Note: I plan to discuss only some of the slides, the others (O) remaining available for your reading pleasure (?). But, consonant with requirements for a professional program, I expect that you will read them.

As a consequence of an ether explosion while working in his organic chemistry lab, a 25-year-old graduate student suffers extensive 3 rd degree burns over his right arm, face and neck. He rates his pain as excruciating, 10 out of 10. The opioid that is least advisable for controlling the student s pain over the course of several weeks is which one of the following? A. Fentanyl Case 1 B. Morphine C. Meperidine D. Buprenorphine

Case 2 An 82 year-old woman with end-stage hepatic cancer is provided with morphine to reduce her pain and suffering. While she has been on morphine over the past month, she has experienced breakthrough pain requiring increased doses of morphine. Although her pain relief improves with the higher drug dose, over a period of several days the patient s pain returns. This outcome: A. is a consequence of acute dysphoria precipitated by chronic morphine treatment B. is to be expected because she is experiencing tolerance to the analgesic effects of morphine C. is to be expected because she has become dependent on morphine and is experiencing an abstinence syndrome D. is to be expected because her pain is neuropathic in origin, and opioid analgesics control such pain less effectively than they control nociceptive pain E. is related to morphine-induced contraction of the sphincter of Oddi

Case 3 A woman is admitted to Kenmore Mercy hospital with a repeat episode of viral meningitis / aseptic encephalitis. After a suitable workup, the ER nurse administers an IV dose of morphine to treat the woman s pain. Within 30 seconds the patient feels heavy, unable to move her arms and legs, experiences difficulty breathing, intense fear, and anxiety. How do you explain these reactions?

A former heroin addict is maintained on methadone, but succumbs to temptation and buys an opioid on the street. He takes it and rapidly experiences signs of withdrawal. Which opioid did he buy? A. Meperidine B. Heroin C. Pentazocine D. Codeine E. Propoxyphene Case 4

Opioid classification Agonist Strong Mild-to-moderate Opioids with mixed actions Agonist-antagonist (Ag-Antag) Partial agonist Antagonist

Strong agonists Morphine* Heroin* Hydromorphone (DILAUDID) Oxymorphone (NUMORPHAN) Methadone (DOLOPHINE)* Meperidine (DEMEROL)* Fentanyl (SUBLIMAZE)* Levorphanol (LEVO-DROMORAN)

Metabolism of Heroin N CH 3 Heroin is biologically inactive In the body it is converted to MAM and then into morphine MAM and morphine are responsible for the effects elicited upon injection of heroin O H 3 CC O H 3 CC O O O HEROIN O N N O CH 3 CH 3 OH O CCH 3 MONOACETYLMORPHINE HO O OH MORPHINE

Methadone (Dolophine) µ-agonist Similar to morphine Prolonged use give rise to tolerance Uses: Relief of pain Treatment of opioid abstinence Treatment of opioid dependence Oral efficacy! O CH 3 CH 2 C C CH 3 CH 3 N CH 3 CH 3 N CH 3 HC CH 3 CH 3 O CH 2

Opioid Withdrawal Syndrome W/i hours of missing first dose of morphine sense of intense fear (this can be alleviated by a placebo) 8-16 hrs: lacrimation, rhinorrhea (as in a severe head cold), yawning, sweating, mydriasis, anorexia, nervousness, irritability, tremors, increased anxiety and fear, restless sleep

W/i 36 hrs: skeletal muscle fasciculation and twitch severe/painful cramps develop in legs and stomach intense/uncontrolled vomiting, salivation, diarrhea, and urination weakness, depression, chilliness/sweating, gooseflesh ("cold turkey"), muscle spasms, kicking movements ("kicking the habit"). patient is unable to sleep; respiratory rate, blood pressure, temperature, blood sugar, basal metabolic rate Withdrawal syndrome reaches its peak within 48-72 hours, and subsides over the next 10 days. Withdrawal reaction is evidence for physical dependence.

Intensity of withdrawal reaction depends Half-life of drug being used For morphine, with a short half-life, symptoms of abstinence are intense but brief. For methadone, with a long-half-life, symptoms are less intense but more prolonged. Degree of physical dependence Withdrawal syndrome of methadone and codeine qualitatively the same but less intense than for morphine.

It is to be emphasized that.. Although withdrawal from opioids is unpleasant, the opioid withdrawal syndrome is rarely dangerous to the patient. In contrast, withdrawal from CNS depressants (barbiturates; alcohol) can be lethal.

Methadone Why is it used in treatment of opioid dependence? Methadone withdrawal is Slower in onset Longer in duration Much less intense Why don t opioid addicts like it?

Meperidine (Demerol) O C O CH 2 CH 3 μ-agonist. Actions are similar to morphine. In equianalgesic doses produces as much sedation, respiratory depression, and euphoria as does morphine. The rise in bile duct pressure is thought to be less than that caused by morphine. Constipation, urinary retention less common than with morphine. N CH 3

Meperidine toxicity Meperidine N-demethylation Normeperidine Large, repeated does can lead to an excitatory syndrome Hallucinations; tremors; muscle twitches; dilated pupils; hyper-reflexia; convulsions Due to the accumulation of normeperidine t 1/2 15-20 hours (meperidine=3 hours) Not drug of choice for treatment of severe, prolonged pain

Fentanyl A µ-agonist. 80-times more potent than morphine as an analgesic. USES: For anesthesia and post-op analgesia. Duragesic (transdermal patch) releases fentanyl over a period of 72 hours (for treatment of chronic pain; cancer pain) Patient controlled anesthesia (Actiq) H N N C O CH 2 CH 2 CH 2 CH 3

Mild-to-Moderate Agonists Codeine Oxycodone (OXYCONTIN) Hydrocodone (VICODIN) Propoxyphene (DARVON) N CH 3 N CH 3 OH N CH 3 H 3 CO O OH H 3 CO O O H 3 CO O O CODEINE OXYCODONE HYDROCODONE

Codeine High oral/parental ratio Partially protected from conjugation by the methyl group at C3 Has very low affinity for opioid receptors Analgesic efficacy is due to its conversion to morphine Polymorphisms in cytochrome P450 isoform CYP2D6 Dispensed alone or in combination with aspirin or acetaminophen

Norcodeine Codeine-6-Glucuronide 10-15% CYP3A4 Codeine UGT 50-70% CYP2D6 0-15% Morphine UGT CYP3A4 CYP2C8 Normorphine UGT Morphine-3-Glucuronide Morphine-6-Glucuronide

Codeine and gene polymorphisms Neonate without pain relief 57-year-old Ethiopian man who derives no pain relief from codeine 37-year-old Caucasian woman who post-dental procedure derives no pain relief from codeine Question: Is it safe to prescribe codeine for nursing mothers?

Codeine and gene polymorphisms Poor metabolizers Ultra-rapid metabolizers Caucasians (7%) Saudi Arabia, 20% Ethiopia, 29% A newborn died from morphine poisoning when his mother used codeine while breastfeeding. Madadi, et al., Clin. Pharmacol. Ther., 85(1) 31-35 (2009) Weinshilboum, NEJM, 348 (6), 529-537 (2003)

Independent mechanisms of analgesia Hydrocodone Dispensed only in combination with other drugs Acetaminophen (NORCET, VICODIN, LORTAB) Ibuprofen (VICOPROFEN) Oxycodone (OXYCONTIN) Dispensed alone or in combination with Aspirin (PERCODAN) Acetaminophen (PERCOCET) Ibuprofen (COMBUNOX)

Ototoxicity Rapid, progressive, and profound (> 83%) sensorineural hearing loss in patients taking Vicodin Successful rehabilitation with cochlear implants Hearing loss reported with propoxyphene Other ototoxic agents? Antineoplastic agents, such as cisplatin Loop diuretics: Furosemide, ethacrynic acid Analgesics: Aspirin Macrolide antibiotics: erythromycin Aminoglycoside antibiotics: gentamycin

Opioids with mixed actions Agonist-Antagonist Opioids Substances that appear to be agonists at some receptors but antagonists at others. Pentazocine (Talwin; Talwin-NX) Butorphanol (Stadol) Partial agonists: Buprenorphine (Buprenex; Suboxone)*

Drug Action at μ and κ Receptors Pure Opioid Agonists Morphine, codeine, meperidine, and other morphine-like agents Agonist-Antagonist Opioids Pentazocine, butorphanol Buprenorphine Receptor Subtype μ Agonist Antagonist Partial agonist κ Agonist Agonist Antagonist Pure Opioid Antagonists Naloxone, naltrexone Antagonist Antagonist

Agonist-Antagonist Opioids Will discuss Buprenorphine Pentazocine Will not discuss Levorphanol Levallorphan Butorphanol

Pentazocine The intrinsic µ antagonistic activity is sufficient to afford advantages over morphine as analgesic 20 mg respiration = 10 mg morphine Doses do not cause proportionate depression of respiration But, high doses BP; HR Cardiac work in patients with coronary artery disease May precipitate withdrawal when given to µ- opioid dependent individual

Pentazocine Talwin-NX (50mg Talwin + 0.5mg naloxone) Oral pill laced with naloxone, to prevent abuse potential through injection. The added naloxone is degraded in liver. If oral pill is powdered for injection naloxone produces aversive effects in individuals dependent on opiods.

Levorphanol [LEVO-DROMORAN] Levallorphan OH 3 OH 3 17 N CH 3 17 N CH-CH CH 2 H 6 Strong agonist H 6 Ag-antag Levorphanol Only commercially available agonist of the morphinan series Pharmacological effects parallel those of morphine Clinical reports suggest that levorphanol may produce less vomiting and nausea Metabolized less rapidly than morphine Elimination half-life = 12-16 hrs Repeated administration can lead to accumulation of the drug in the plasma

Ag-Antag Opioids N CH 2 Butorphanol (Stadol) HO More potent that morphine (on a per weight basis) 2-3 mg 10 mg morphine Onset, peak activity, duration morphine Lowest abuse potential Actions similar to pentazocine. Pulmonary arterial BP work of heart Thus, less useful in patients with CHF or MI

AG-ANTAG SUMMARY Pentazocine* Nalbuphine Butorphanol* Why developed? Same intensity of side effects as morphine Psychotomimetic effects Precipitate withdrawal effects in addicts Analgesia has ceiling effect * Pulmonary arterial tension HR Cardiac work

Ag-Antag Opioids Buprenorphine (Buprenex) HO N CH 2 HO CH 3 CH 3 CH 3 OCH 3 Highly lipophilic opioid derivative of thebaine Partial µ-agonist; 25-50-fold more potent than morphine. 0.4 mg 10 mg morphine (im) Produces analgesia and other CNS effects to those of morphine. Duration of analgesia is longer than that of morphine. On a per weight basis, more potent and longer lasting than morphine.

Ag-Antag Opioids Buprenorphine (Buprenex) Used as analgesic Absorbed well by most routes, including sublingual Approved for use as maintenance drug for opioid-dependent subjects Suboxone (Buprenorphine + naloxone)

Opioid Antagonists Opioid antagonists produce few effects unless opioid agonists have been administered previously. Naloxone Naltrexone* Devoid of agonist activities Probably interact with all opioid receptors (albeit with different affinities)

Naloxone: Clinical use 1. In treatment of opioid toxicity, especially respiratory depression. In patients with respiratory depression small doses IM or IV promptly reverse effects of µ-opioid agonists Respiratory rates, within 1-2 minutes Sedation is reversed BP, if reduced, returns to normal In dependent subjects PPTs withdrawal syndrome.

Naloxone (Narcan) 2. In diagnosis of physical dependence on opioids. In opioid-dependent subjects: IM small doses of naloxone precipitate moderate-to-severe withdrawal syndrome. Symptoms appear within minutes and subside in about 2 hours. Severity and duration? Are related to dose and degree of dependence

Oral efficacy Naloxone 100-1000 times less potent orally than parenterally Naltrexone Efficacious by the oral route Elimination t 1/2 1 hour Duration of action 24 hours

Extended-release naltrexone

Naltrexone (Trexan) Used in long-term management of opioid addiction The long duration of action serves as a safety valve after detoxification for patients with high motivation to remain opioid-free

As a consequence of an ether explosion while working in his organic chemistry lab, a 25-year-old graduate student suffers extensive 3 rd degree burns over his right arm, face and neck. He rates his pain as excruciating, 10 out of 10. The opioid that is least advisable for controlling the student s pain over the course of several weeks is which one of the following? A. Fentanyl Case 1 B. Morphine C. Meperidine D. Buprenorphine

Case 2 An 82 year-old woman with end-stage hepatic cancer is provided with morphine to reduce her pain and suffering. While she has been on morphine over the past month, she has experienced breakthrough pain requiring increased doses of morphine. Although her pain relief improves with the higher drug dose, over a period of several days the patient s pain returns. This outcome: A. is a consequence of acute dysphoria precipitated by chronic morphine treatment B. is to be expected because she is experiencing tolerance to the analgesic effects of morphine C. is to be expected because she has become dependent on morphine and is experiencing an abstinence syndrome D. is to be expected because her pain is neuropathic in origin, and opioid analgesics control such pain less effectively than they control nociceptive pain E. is related to morphine-induced contraction of the sphincter of Oddi

Case 3 A woman is admitted to Kenmore Mercy hospital with a repeat episode of viral meningitis / aseptic encephalitis. After a suitable workup, the ER nurse administers an IV dose of morphine to treat the woman s pain. Within 30 seconds the patient feels heavy, unable to move her arms and legs, experiences difficulty breathing, intense fear, and anxiety. How do you explain these reactions?

A former heroin addict is maintained on methadone, but succumbs to temptation and buys an opioid on the street. He takes it and rapidly experiences signs of withdrawal. Which opioid did he buy? A. Meperidine B. Heroin C. Pentazocine D. Codeine E. Propoxyphene Case 4

The End